Search Results - "Powell, Sue M"

Androgen receptor modulatory miR-1271-5p can promote hormone sensitive prostate cancer cell growth by Kalofonou, Foteini, Leach, Damien A, Powell, Sue M, Waxman, Jonathan, Fletcher, Claire E, Bevan, Charlotte L

“…In most patients with advanced prostate cancer treated with hormonal therapy, androgen independence eventually emerges, leading to death. Androgen receptor…”
Get full text

FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth by BROOKE, Greg N, CULLEY, Rachel L, WAIT, Robin, WAXMAN, Jonathan, WALKER, Marjorie M, BEVAN, Charlotte L, DART, D. Alwyn, MANN, David J, GAUGHAN, Luke, MCCRACKEN, Stuart R, ROBSON, Craig N, SPENCER-DENE, Bradley, GAMBLE, Simon C, POWELL, Sue M

“…Progression of prostate cancer is highly dependent upon the androgen receptor pathway, such that knowledge of androgen-regulated proteins is vital to…”
Get full text

Coordinated AR and microRNA regulation in prostate cancer by Eringyte, Ieva, Zamarbide Losada, Joanna N., Powell, Sue M., Bevan, Charlotte L., Fletcher, Claire E.

“…The androgen receptor (AR) remains a key driver of prostate cancer (PCa) progression, even in the advanced castrate-resistant stage, where testicular androgens…”
Get full text

Hey1, a Mediator of Notch Signaling, Is an Androgen Receptor Corepressor by Belandia, Borja, Powell, Sue M., García-Pedrero, Juana M., Walker, Marjorie M., Bevan, Charlotte L., Parker, Malcolm G.

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Handheld ISFET Lab-on-Chip Detection of TMPRSS2-ERG and AR mRNA for Prostate Cancer Prognostics by Broomfield, Joseph, Kalofonou, Melpomeni, Franklin, Sylvia, Powell, Sue M., Pataillot-Meakin, Thomas, Moser, Nicolas, Bevan, Charlotte L., Georgiou, Pantelis

“…Ion-sensitive field-effect transistors (ISFETs) in combination with unmodified complementary metal oxide semiconductors present a point-of-care platform for…”
Get full text

Handheld ISFET Lab-on-Chip detection of TMPRSS2-ERG and AR mRNA for prostate cancer prognostics by Broomfield, Joseph, Kalofonou, Melpomeni, Franklin, Sylvia, Powell, Sue M, Pataillot-Meakin, Thomas, Moser, Nicolas, Bevan, Charlotte L, Georgiou, Pantelis

“…Ion-sensitive field-effect transistors (ISFETs) in combination with unmodified complementary metal oxide semiconductors present a point-of-care platform for…”
Get full text

Detection of YAP1 and AR-V7 mRNA for Prostate Cancer Prognosis Using an ISFET Lab-On-Chip Platform by Broomfield, Joseph, Kalofonou, Melpomeni, Pataillot-Meakin, Thomas, Powell, Sue M., Fernandes, Rayzel C., Moser, Nicolas, Bevan, Charlotte L., Georgiou, Pantelis

“…Prostate cancer (PCa) is the second most common cause of male cancer-related death worldwide. The gold standard of treatment for advanced PCa is androgen…”
Get full text

Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells[S] by Brooke, Greg N., Gamble, Simon C., Hough, Michael A., Begum, Shajna, Dart, D. Alwyn, Odontiadis, Michael, Powell, Sue M., Fioretti, Flavia M., Bryan, Rosie A., Waxman, Jonathan, Wait, Robin, Bevan, Charlotte L.

“…Current therapies for prostate cancer include antiandrogens, inhibitory ligands of the androgen receptor, which repress androgen-stimulated growth. These…”
Get full text

Role of the HSP90-Associated Cochaperone p23 in Enhancing Activity of the Androgen Receptor and Significance for Prostate Cancer by Reebye, Vikash, Querol Cano, Laia, Lavery, Derek N, Brooke, Greg N, Powell, Sue M, Chotai, Deepa, Walker, Marjorie M, Whitaker, Hayley C, Wait, Robin, Hurst, Helen C, Bevan, Charlotte L

“…Prostate tumor growth initially depends on androgens, which act via the androgen receptor (AR). Despite androgen ablation therapy, tumors eventually progress…”
Get full text

Engineered repressors are potent inhibitors of androgen receptor activity by Brooke, Greg N, Powell, Sue M, Lavery, Derek N, Waxman, Jonathan, Buluwela, Laki, Ali, Simak, Bevan, Charlotte L

“…Prostate cancer growth is dependent upon the Androgen Receptor (AR) pathway, hence therapies for this disease often target this signalling axis. Such therapies…”
Get full text

Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene by Wang, Qin, Holmes, David I.R., Powell, Sue M., Lu, Qi L., Waxman, Jonathan

“…A PCR-based subtractive hybridisation technique was used to identify genes involved in stromal-epithelial interactions in prostate cancer. Eight genes were…”
Get full text

WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer by Leach, Damien A, Powell, Sue M, Bevan, Charlotte L

“…Prostate cancer has, for decades, been treated by inhibiting androgen signalling. This is effective in the majority of patients, but inevitably resistance…”
Get full text